Real-World Outcomes of Baricitinib and Ritlecitinib in Refractory Alopecia Areata: Response Predictors and Relapse After Discontinuation or Dose Reduction.
Saved in:
| Title: | Real-World Outcomes of Baricitinib and Ritlecitinib in Refractory Alopecia Areata: Response Predictors and Relapse After Discontinuation or Dose Reduction. |
|---|---|
| Authors: | Hayashi R; Department of Dermatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan., Takamura S; Department of Dermatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan., Fukuda T; Department of Dermatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan. |
| Source: | The Journal of dermatology [J Dermatol] 2026 May; Vol. 53 (5), pp. 746-757. Date of Electronic Publication: 2026 Mar 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1346-8138 (Electronic) Linking ISSN: 03852407 NLM ISO Abbreviation: J Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1346-8138 |
|---|---|
| DOI: | 10.1111/1346-8138.70241 |
